Syndax Pharmaceuticals

Upcoming events – crucial cancer data for Tocagen and Syndax

Tocagen could soar or sink on interim brain cancer data, while judgement day approaches for Syndax.

AACR 2019 – Entinostat turns Syndax’s frown upside down

After two checkpoint combo trials flopped last month Syndax celebrates an unexpected win in a third.

March 08, 2019

Syndax suspends entinostat work after two trial flops

November 08, 2017

“Surprise” SITC late-breaker breaks Five Prime

June 08, 2017

Asco event analyser – Puma investors’ Aphinity for Roche data

May 19, 2017

Snippet roundup: Bladder cancer nod for Keytruda and success for Syndax in melanoma

April 20, 2016

Scuttled IPOs cast pall on struggling biotech sector

April 12, 2016

Audacity pays off for the few newly public biotechs

March 17, 2016

Revisiting a predictor of failure in the post-Celator world

October 14, 2015

Venture treasure bath for oncology, pennies for others